AstraZeneca boosted by US approval of asthma drug
LOUISA GAULT
Business
23 Jul 2006
SHARES in AstraZeneca are expected to rise tomorrow morning after Britain’s second largest pharmaceutical company said yesterday that it had won US approval for its asthma drug Symbicort. The approval from the US Food and Drug Administration came... read more...
posted by Bank Report at
6:16 PM
0 Comments:
Post a Comment
<< Home